Compare Stocks → Wall Street Legend Issues New NVDA Warning (From Chaikin Analytics) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:KINNYSE:SOR Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeKINKindred Biosciences$9.25$9.22$3.46▼$9.28$420.52M1.3840,890 shs178,496 shsSORSource Capital$41.25-1.3%$41.64$36.48▼$42.92$338.25M0.6813,782 shs3,089 shsBeginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceKINKindred Biosciences0.00%0.00%0.00%0.00%0.00%SORSource Capital-0.02%+1.63%+0.17%+4.37%+13.47%Wall Street Legend Issues New NVDA Warning (Ad)Legendary Stockpicker: "Buy this A.I. stock NOW" His award-winning system pinpointed NVDA and META before both stocks doubled. Now it's flashing "BUY" on this under-the-radar A.I. stock.Click here for the stock detailsMarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationKINKindred BiosciencesN/AN/AN/AN/AN/AN/AN/AN/ASORSource CapitalN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceKINKindred BiosciencesN/AN/AN/AN/ASORSource CapitalN/AN/AN/AN/ASales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookKINKindred Biosciences$42.16M9.97N/AN/A$1.75 per share5.29SORSource Capital$54.57M6.20N/AN/AN/A∞Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateKINKindred Biosciences-$21.80M-$0.55N/AN/AN/A-529.26%-54.19%-39.76%N/ASORSource CapitalN/AN/A0.00∞N/AN/AN/AN/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthKINKindred BiosciencesN/AN/AN/AN/AN/ASORSource Capital$2.506.06%+33.57%N/A1 YearsLatest KIS, SOR, KIN, VRC, and FTZ DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date4/19/2024SORSource Capitalmonthly$0.20836%8/15/20248/15/20248/30/20244/18/2024SORSource Capitalmonthly$0.20836%7/16/20247/16/20247/31/20241/26/2024SORSource Capitalmonthly$0.20836.3%5/15/20245/16/20245/31/20241/25/2024SORSource Capitalmonthly$0.20836.3%4/17/20244/18/20244/30/2024(Data available from 1/1/2013 forward)DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioKINKindred Biosciences0.197.027.02SORSource CapitalN/AN/AN/AOwnershipInstitutional OwnershipCompanyInstitutional OwnershipKINKindred Biosciences66.89%SORSource Capital13.15%Insider OwnershipCompanyInsider OwnershipKINKindred Biosciences13.69%SORSource Capital76.97%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableKINKindred Biosciences6345.46 millionN/AOptionableSORSource CapitalN/A8.20 million1.89 millionNot OptionableKIS, SOR, KIN, VRC, and FTZ HeadlinesSourceHeadlineInternational Assets Investment Management LLC Invests $807,000 in Source Capital, Inc. (NYSE:SOR)marketbeat.com - April 24 at 4:25 AMSource Capital, Inc. Declares Monthly Dividend of $0.21 (NYSE:SOR)marketbeat.com - April 19 at 7:58 AMSource Capital, Inc. to Issue Monthly Dividend of $0.21 (NYSE:SOR)marketbeat.com - April 18 at 5:02 PMSource Capital, Inc. (NYSE:SOR) Short Interest Up 33.3% in Marchmarketbeat.com - April 15 at 9:14 PMFive major capital improvement projects coming to Havasuhavasunews.com - April 12 at 5:52 PMA multi-trillion-dollar bull market is coming for assets that benefit from higher inflation, top macro strategist saysmsn.com - April 4 at 4:20 PMDigital Assets Platform Matrixport Launches New Prime Brokerage Servicecrowdfundinsider.com - April 4 at 11:19 AMMatrixport Unveils 'Phoenix Prime' to Pioneer Next-Gen Crypto Prime Brokerage Erafinance.yahoo.com - April 3 at 9:03 AMSource Capital, Inc. (NYSE:SOR) Sees Large Decrease in Short Interestmarketbeat.com - March 29 at 6:41 AMClear Capital extends its partnership with Cherrehousingwire.com - March 27 at 4:48 PMNiti Aayog comes up with roadmap to boost exports from MSME sectorbusiness-standard.com - March 14 at 9:00 AMArcapita Capital Raises Logistics Fund With SWFswfinstitute.org - March 13 at 2:52 PMNiti comes up with roadmap to boost exports from MSMEsmsn.com - March 13 at 9:51 AMMainstream Renewable Power to develop 440 MW of wind power in the Philippinesevwind.es - March 11 at 9:18 PMAnother Look at Humanity Through Sor Sen’s Botanical Imagerythisdaylive.com - March 3 at 1:28 AMLet’s Rise To Stop The Bleedingmsn.com - March 1 at 12:59 AMAristotle Capital Small Cap Equity Q4 2023 Commentaryseekingalpha.com - February 27 at 12:15 AMCan Bola Tinubu revive Africa’s sleeping giant?msn.com - February 26 at 1:22 AMRuto softens his line on China as Kenya seeks $1bn loanmsn.com - February 26 at 1:22 AMFPA Source Capital Inc. Fourth Quarter 2023 Commentaryseekingalpha.com - February 26 at 1:22 AMCapital One Is Buying Discover Financial for $35 Billionmsn.com - February 21 at 1:29 AMCapital One to buy Discover for $35.3 bnmsn.com - February 19 at 11:35 PMCapital One is Buying Discover Financialmsn.com - February 19 at 1:35 PMCapital One is Buying Discover Financial, Sources Saywsj.com - February 19 at 1:35 PMMedia Sentiment Over TimeTop HeadlinesViking Therapeutics Surges Sentiment for Triple Threat GLP-1PillApril 3, 2024 6:20 AMView Viking Therapeutics Surges Sentiment for Triple Threat GLP-1Pill3 Key Stocks Helping to Drive the EV RaceApril 12, 2024 9:25 AMView 3 Key Stocks Helping to Drive the EV RaceHow to Protect your Portfolio Against a Rising VIXApril 10, 2024 9:22 AMView How to Protect your Portfolio Against a Rising VIXThis Underrated Natural Gas Stock Could Rally Double-Digits SoonApril 1, 2024 9:15 AMView This Underrated Natural Gas Stock Could Rally Double-Digits Soon3 Energy Stocks to Consider as the Sector Breaks OutApril 8, 2024 8:55 AMView 3 Energy Stocks to Consider as the Sector Breaks OutAll Headlines Company DescriptionsKindred BiosciencesNASDAQ:KINKindred Biosciences, Inc. is a development-stage biopharmaceutical company, which focuses on saving and improving the lives of pets. The company was founded by Richard Chin and Denise M. Bevers on September 25, 2012 and is headquartered in Burlingame, CA.Source CapitalNYSE:SORSource Capital, Inc. is a close-ended balanced fund launched and managed by First Pacific Advisors, LLC. The fund invests in the public equity markets of the United States. It seeks to invest in the stocks of companies operating across diversified sectors. The fund primarily invests in value stocks of small to mid cap companies. It employs fundamental analysis with a bottom-up stock selection approach, focusing on such factors as high liquidity, relatively unleveraged balance sheets, and long-term ability to earn above-average returns on capital to create its portfolio. The fund benchmarks the performance of its portfolio against the Russell 2500 Index, the S&P 500 Index, and the Nasdaq Composite Index. Source Capital, Inc. was formed in June 1, 1968 and is domiciled in the United States. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
